379 related articles for article (PubMed ID: 28120845)
21. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort.
Lee JE; Lee S; Lee H; Song YM; Lee K; Han MJ; Sung J; Ko G
PLoS One; 2013; 8(5):e63514. PubMed ID: 23717441
[TBL] [Abstract][Full Text] [Related]
22. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
23. Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.
Ntuli L; Mtshali A; Mzobe G; Liebenberg LJ; Ngcapu S
Front Cell Infect Microbiol; 2022; 12():927131. PubMed ID: 35873158
[TBL] [Abstract][Full Text] [Related]
24. Microbiota and HPV: The role of viral infection on vaginal microbiota.
Santella B; Schettino MT; Franci G; De Franciscis P; Colacurci N; Schiattarella A; Galdiero M
J Med Virol; 2022 Sep; 94(9):4478-4484. PubMed ID: 35527233
[TBL] [Abstract][Full Text] [Related]
25. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
[TBL] [Abstract][Full Text] [Related]
26. Vaginal Microbiota Changes Caused by HPV Infection in Chinese Women.
Zhang Y; Xu X; Yu L; Shi X; Min M; Xiong L; Pan J; Zhang Y; Liu P; Wu G; Gao G
Front Cell Infect Microbiol; 2022; 12():814668. PubMed ID: 35800384
[TBL] [Abstract][Full Text] [Related]
27. Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
Yang Z; Zhang Y; Stubbe-Espejel A; Zhao Y; Liu M; Li J; Zhao Y; Tong G; Liu N; Qi L; Hutchins A; Lin S; Li Y
PLoS One; 2022; 17(8):e0270521. PubMed ID: 35944043
[TBL] [Abstract][Full Text] [Related]
28. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
29. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis.
Borgogna JC; Shardell MD; Santori EK; Nelson TM; Rath JM; Glover ED; Ravel J; Gravitt PE; Yeoman CJ; Brotman RM
BJOG; 2020 Jan; 127(2):182-192. PubMed ID: 31749298
[TBL] [Abstract][Full Text] [Related]
30. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
[TBL] [Abstract][Full Text] [Related]
31. Vaginal Microbiota and Mucosal Immune Markers in Women With Vulvovaginal Discomfort.
Mitchell CM; Watson L; Mitchell AJ; Hyrien O; Bergerat A; Valint DJ; Pascale A; Hoffman N; Srinivasan S; Fredricks DN
Sex Transm Dis; 2020 Apr; 47(4):269-274. PubMed ID: 32044865
[TBL] [Abstract][Full Text] [Related]
32. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system.
Thapa M; Welner RS; Pelayo R; Carr DJ
J Immunol; 2008 Jan; 180(2):1098-106. PubMed ID: 18178850
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study.
Gao W; Weng J; Gao Y; Chen X
BMC Infect Dis; 2013 Jun; 13():271. PubMed ID: 23758857
[TBL] [Abstract][Full Text] [Related]
34. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
35. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis.
Lin W; Zhang Q; Chen Y; Dong B; Xue H; Lei H; Lu Y; Wei X; Sun P
Sci Rep; 2022 Feb; 12(1):2812. PubMed ID: 35181685
[TBL] [Abstract][Full Text] [Related]
36. HPV-associated cervicovaginal microbiome and host metabolome characteristics.
Zhang Y; Wu X; Li D; Huang R; Deng X; Li M; Du F; Zhao Y; Shen J; Chen Y; Zhang P; Hu C; Xiao Z; Wen Q
BMC Microbiol; 2024 Mar; 24(1):94. PubMed ID: 38519882
[TBL] [Abstract][Full Text] [Related]
37. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
38. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
[TBL] [Abstract][Full Text] [Related]
39. Comparison of vaginal microbiota sampling techniques: cytobrush versus swab.
Mitra A; MacIntyre DA; Mahajan V; Lee YS; Smith A; Marchesi JR; Lyons D; Bennett PR; Kyrgiou M
Sci Rep; 2017 Aug; 7(1):9802. PubMed ID: 28852043
[TBL] [Abstract][Full Text] [Related]
40. Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection.
Mei L; Wang T; Chen Y; Wei D; Zhang Y; Cui T; Meng J; Zhang X; Liu Y; Ding L; Niu X
J Transl Med; 2022 Jan; 20(1):12. PubMed ID: 34980148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
